Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norethisterone to Ethinylestradiol Conversion Study
NCT02170038Phase 1Completed
- Sponsor
- Bayer
- Start
- Jun 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of norethisterone enanthate in pregnancy, sponsored by Bayer. Primary endpoints: Maximum observed drug concentration of ethinylestradiol at steady state at day 21 and Area under the concentration-time curve of ethinylestradiol at steady state at day 21. Started Jun 2014; status: completed.
02
Drugs
norethisterone enanthate
03
Conditions
pregnancy
Beyond the preview
Go deeper on NCT02170038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02170038.